Association of Systemic Collagen Type IV Formation with Survival among Patients Undergoing Hemodialysis

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Leeming, Diana J ^a   Karsdal, Morten A ^a   Rasmussen, Lars M ^b   Scholze, Alexandra ^b   Tepel, Martin ^b  

^a NORDIC BIOSCIENCE A S   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; PROCOLLAGEN TYPE 4 AMINOPROPEPTIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; SURVIVAL; SYSTOLIC BLOOD PRESSURE;

AGED; COHORT STUDIES; COLLAGEN; COLLAGEN TYPE IV; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROSIS; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PEPTIDES; PROPORTIONAL HAZARDS MODELS; PROTEIN STRUCTURE, TERTIARY; RENAL DIALYSIS; RISK; TREATMENT OUTCOME;

EID: 84882792259     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071050     Document Type: Article

References (36)

1. Kim H, Kim M, Kim H, Kim YL, Kang SW, et al. (2013) Early referral to a nephrologist improved patient survival: prospective cohort study for end-stage renal disease in Korea. PLoS One 8: e55323 doi: 10.1371/journal.pone.0055323.
2. Wong G, Howard K, Chapman JR, Chadban S, Cross N, et al. (2012) Comparative survival and economic benefits of deceased donor kidney transplantation and dialysis in people with varying ages and co-morbidities. PLoS One 2012;7: e29591 doi: 10.1371/journal.pone.0029591.
3. Kovesdy CP, Lott EH, Lu JL, Malakauskas SM, Ma JZ, et al. (2012) Hyponatremia, hypernatremia, and mortality in patients with chronic kidney disease with and without congestive heart failure. Circulation 125: 677-684.
4. DeJager DJ, Grootendorst DC, Jager KJ, van Dijk PC, Tomas LMJ, et al. (2009) Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA 302: 1782-1789.
5. Gross ML, Ritz E, (2008) Hypertrophy and fibrosis in the cardiomyopathy of uremia-beyond coronary heart disease. Semin Dial 21: 308-318.
6. Miyamoto T, Carrero JJ, Stenvinkel P, (2011) Inflammation as a risk factor and target for therapy in chronic kidney disease. Curr Opin Nephrol Hypertens 20: 662-668.
7. Molnar MZ, Keszei A, Czira ME, Rudas A, Ujszaszi A, et al. (2010) Evaluation of the malnutrition-inflammation score in kidney transplant recipients. Am J Kidney Dis 56: 102-111.
8. Cho KH, Kim HJ, Rodriguez-Iturbe B, Vaziri ND, (2009) Niacin ameliorates oxidative stress, inflammation, proteinuria, and hypertension in rats with chronic renal failure. Am J Physiol Renal Physiol 297: F106-113.
9. Pohlers D, Brenmoehl J, Löffler I, Müller CK, Leipner C, et al. (2009) TGF-beta and fibrosis in different organs- molecular pathway imprints. Biochim Biophys Acta 1792: 746-756.
10. Semple D, Smith K, Bhandari S, Seymour AM, (2011) Uremic cardiomyopathy and insulin resistance: a critical role for akt? J Am Soc Nephrol 22: 207-215.
11. Zolty R, Hynes PJ, Vittorio TJ, (2008) Severe left ventricular systolic dysfunction may reverse with renal transplantation: uremic cardiomyopathy and cardiorenal syndrome. Am J Transplant 8: 2219-2224.
12. Elkareh J, Kennedy DJ, Yashaswi B, Vetteth S, Shidyak A, et al. (2007) Marinobufagenin stimulates fibroblast collagen production and causes fibrosis in experimental uremic cardiomyopathy. Hypertension 49: 215-224.
13. Keller F, Lyreal Y, Schuppan D, (1992) Raised concentrations of the carboxy terminal propeptide of type IV (basement membrane) procollagen (NC1) in serum and urine of patients with glomerulonephritis. Eur J Clin Invest 22: 175-181.
14. Dixit SN, Stuart JM, Seyer JM, Risteli J, Timpl R, et al. (1981) Type IV collagens' isolation and characterization of 7S collagen from human kidney, liver and lung. Coll Relat Res 1: 549-556.
15. Karttunen T, Risteli J, Autio-Harmainen H, Risteli L, (1986) Effect of age and diabetes on type IV collagen and laminin in human kidney cortex. Kidney Int 30: 586-591.
16. Vleming LJ, Baelde JJ, Westendorp RG, Daha MR, van Es LA, et al. (1995) Progression of chronic renal disease in humans is associated with the deposition of basement membrane components and decorin in the interstitial extracellular matrix. Clin Nephrol 44: 211-219.
17. Araki S, Haneda M, Koya D, Isshiki K, Kume S, et al. (2010) Association between urinary type IV collagen level and deterioration of renal function in type 2 diabetic patients without overt proteinuria. Diabetes Care 33: 1805-1810.
18. Morita M, Uchigata Y, Hanai K, Ogawa Y, Iwamoto Y, (2011) Association of urinary type IV collagen with GFR decline in young patients with type 1 diabetes. Am J Kidney Dis 58: 915-920.
19. Leeming DJ, Nielsen MJ, Dai Y, Veidal SS, Vassiliadis E, et al. (2012) Enzyme-linked immunosorbent serum assay specific for the 7S domain of collagen type IV (P4NP7S): A marker related to the extracellular matrix remodeling during liver fibrogenesis. Hepatol Res 42: 482-493.
20. Niemelä O, Risteli L, Sotaniemi EA, Stenbäck F, Risteli J, (1988) Serum antigens reflecting basement membrane and type III procollagen metabolism in primary biliary cirrhosis. J Hepatol 6: 307-314.
21. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM, (2002) The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 62: 1524-1538.
22. Henderson NC, Sheppard D, (2012) Integrin-mediated regulation of TGFβ in fibrosis. Biochim Biophys Acta doi: 10.1016/j.bbadis.2012.10.005. [Epub ahead of print].
23. Lekawanvijit S, Kompa AR, Manabe M, Wang BH, Langham RG, et al. (2012) Chronic kidney disease-induced cardiac fibrosis is ameliorated by reducing circulating levels of a non-dialysable uremic toxin, indoxyl sulfate. PLoS One 7: e41281.
24. Wynn TA, Ramalingam TR, (2012) Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med 18: 1028-1040.
25. Zeisberg M, Duffield JS, (2010) Resolved: EMT produces fibroblasts in the kidney. J Am Soc Nephrol 21: 1247-1253.
26. Thornalley PJ, Rabbani N, (2011) Protein damage in diabetes and uremia-identifying hotspots of proteome damage where minimal modification is amplified to marked pathophysiological effect. Free Radic Res 45: 89-100.
27. Barasch E, Gottdiener JS, Aurigemma G, Kitzman DW, Han J, et al. (2011) The relationship between serum markers of collagen turnover and cardiovascular outcome in the elderly: the Cardiovascular Health Study. Circ Heart Fail 4: 733-739.
28. Losi MA, Memoli B, Contaldi C, Barbati G, Del Prete M, et al. (2010) Myocardial fibrosis and diastolic dysfunction in patients on chronic haemodialysis. Nephrol Dial Transplant 25: 1950-1954.
29. Murakami M, Kusachi S, Nakahama M, Naito I, Murakami T, et al. (1998) Expression of the alpha 1 and alpha 2 chains of type IV collagen in the infarct zone of rat myocardial infarction. J Mol Cell Cardiol 30: 1191-1202.
30. Herzog CA, Ma JZ, Collins AJ, (1998) Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med 339: 799-805.
31. Leask A, (2010) Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation. Circ Res 106: 1675-1680.
32. Gu HP, Lin S, Xu M, Yu HY, Du XJ, et al. (2012) Up-regulating relaxin expression by G-quadruplex interactive ligand to achieve antifibrotic action. Endocrinology 153: 3692-3700.
33. Briet M, Burns KD, (2012) Chronic kidney disease and vascular remodelling: molecular mechanisms and clinical implications. Clin Sci (Lond) 123: 399-416.
34. Törnig J, Amann K, Ritz E, Nichols C, Zeier M, et al. (1996) Arteriolar wall thickening, capillary rarefaction and interstitial fibrosis in the heart of rats with renal failure: The effect of Ramipril, Nifedipine and Moxonidine. J Am Soc Nephrol 7: 667-675.
35. Scholze A, Thies C, Cheikhalfraj M, Wittstock A, Pommer W, et al. (2009) Mortality risk in hemodialysis patients with increased arterial stiffness is reduced by attainment of classical clinical performance measures. Am J Nephrol 29: 598-606.
36. Briet M, Pierre B, Laurent S, London GM, (2012) Arterial stiffness and pulse pressure in CKD and ESRD. Kidney Int 82: 388-400.